Open Label Placebo
Open Label Placebo is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
The Effects of Open-label Placebos on Acute Stress
Can Labor Pain be Reduced by Open Placebo Intervention? A Bayesian Account for Labor Pain
OLP to Manage Pain in TJA: A Feasibility Study
Measuring the Effects of Complementary Therapies in Chronic Neuropathic Pain
Clinical Trials (8)
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
The Effects of Open-label Placebos on Acute Stress
Can Labor Pain be Reduced by Open Placebo Intervention? A Bayesian Account for Labor Pain
OLP to Manage Pain in TJA: A Feasibility Study
Measuring the Effects of Complementary Therapies in Chronic Neuropathic Pain
Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety
Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion
Non-concealed Placebo Treatment for Menopausal Hot Flushes
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8